As a novel coronavirus spread to a pandemic and shut down countries for weeks, scientists were determined to study the virus. With a desire to help fight the disease, two medical students found inspiration with ClinCapture .
As the COVID-19 pandemic continued, clinical researchers looked for ways to safely continue clinical trials to progress. With FDA guidance, trials were able to resume with the help of technology.
As a Chief Executive Officer (CEO), do you know what to look for when deciding on an electronic data capture (EDC) system?
Clinical data management (CDM) requires the utmost attention, especially with all the details to consider and protocols to adhere to. Overseeing data collection and ensuring accuracy throughout a study comes with its own set of challenges and rules to remember, but don’t worry – we wrote them out for you.
The era of one-size-fits-all medicine is gradually coming to an end, making way for a more personalized
approach to healthcare. Personalized medicine, also known as precision medicine, tailors medical
treatment to the individual characteristics of each patient. This approach not only considers the patient’s
genetic makeup but also factors in lifestyle and environment, ensuring treatments are as effective and
efficient as possible.
Genetic testing in oncology offers unprecedented opportunities for early detection, personalized
treatment, and better patient outcomes. However, the rapid advancement and integration of genetic
testing into cancer care also bring to light significant ethical considerations.
Genetic testing in oncology offers unprecedented opportunities for early detection, personalized
treatment, and better patient outcomes. However, the rapid advancement and integration of genetic
testing into cancer care also bring to light significant ethical considerations.
The integration of digital health technologies into cancer care marks a significant advancement in the field of oncology, reshaping how treatments are administered, monitored, and optimized for patient benefit. From mobile apps to wearable devices, digital health tools are becoming integral in supporting cancer treatment and enhancing patient quality of life.
Precision medicine in oncology is continually evolving, with recent advances in epigenetics presenting
new pathways for understanding and treating cancer more effectively. Epigenetics involves the study of
heritable changes in gene expression that do not involve alterations to the underlying DNA sequence —
essentially, how genes are turned on or off. This blog post delves into how epigenetic factors are being
integrated into oncology to refine cancer treatment, enhance predictive capabilities, and offer new
therapeutic targets.
The integration of genomics into the field of oncology has ushered in a transformative era in cancer care, enhancing both diagnosis and prognosis by allowing clinicians to understand the genetic basis of cancers more deeply. This shift towards a genomics-driven approach enables more precise and targeted treatment strategies, fundamentally altering the oncology landscape.
